Files

Download

Download Full Text (654 KB)

Date

2024

Abstract

With the increasing prevalence of diabetes and obesity in Vermont, GLP-1 agonists are being prescribed more and more to help treat these conditions. Providers at Milton Family Medicine relayed that they have been prescribing them more as well over the recent years and have seen significant benefit for their patients. With increased use of these medications, patients continue to have many questions around how GLP-1 agonists work, their side effects, and how to pay for these expensive medications. There is a need to have education materials available at the office to answer these questions for our patients.

Clinical Site

Family Medicine - Milton UVMMC

Keywords

GLP-1, Diabetes, Obesity, Vermont

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Disciplines

Endocrine System Diseases | Medical Education | Primary Care

Patient guide to starting a GLP-1 agonist

Share

COinS